Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Global | Publication | September 2017
On September 19, 2017, under the framework of the National Economic Emergency Decree, the President of the Republic passed Decree No. 3,085 published in Official Gazette No. 41,239 by which value added tax (VAT) rate reductions of 3% and 5% were established for the following sales of movable goods and services rendered to individuals and legal entities, when paid through electronic means:
This decree implements the VAT rate reduction recently announced by the Executive Branch with the purpose of encouraging electronic payments in order to deal with the current crisis of legal tender.
The VAT rate reduction will not be applicable in the following cases:
Even though the language of the provision is not clear, it appears the decree also excludes transactions involving a VAT collection agent from applying the reduced VAT rate.
The VAT rate reduction will become effective 5 calendar days after the publication of Decree No. 3,085 in the Official Gazette (namely, after September 27, 2017) and will remain in force until December 31, 2017.
Taxpayers will have to determine the applicable requirements for invoices and other relevant documents, as well as when filing VAT returns and paying the corresponding tax liability.
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023